Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Gc inhibition preserves insulin sensitivity and reduces body weight without loss of muscle mass
Richard Gill, Taiyi Kuo
Richard Gill, Taiyi Kuo
View: Text | PDF
Research Article Endocrinology Metabolism

Gc inhibition preserves insulin sensitivity and reduces body weight without loss of muscle mass

  • Text
  • PDF
Abstract

Obesity and type 2 diabetes (T2D) are metabolic diseases with increasing prevalence worldwide. Obesity often leads to T2D. Insulin resistance and impaired β cell function contribute to the onset of hyperglycemia. Previously, we reported that ablation of Gc, encoding a secreted protein with a primary role in vitamin D transport, improved pancreatic β cell function in models of diet-induced insulin resistance. Here, we show that Gc ablation had systemic insulin-sensitizing effects to prevent weight gain, hyperglycemia, and glucose intolerance; lower nonesterified fatty acids and triglycerides; and augment glucose uptake in skeletal muscle and adipose in male mice fed a high-fat diet. Interestingly, weight loss in Gc-ablated mice resulted from selective fat mass loss with preserved lean mass. Moreover, acute Gc inhibition prevented glucose intolerance caused by high-fat feeding. The data suggest that Gc inhibition can increase insulin production in β cells and insulin action in peripheral tissues, while reducing fat mass.

Authors

Richard Gill, Taiyi Kuo

×

Figure 4

Dissociation of body weight, fat mass, and glucose and pyruvate tolerance in GcKO mice.

Options: View larger image (or click on image) Download as PowerPoint
Dissociation of body weight, fat mass, and glucose and pyruvate toleranc...
(A) Experimental design with body weight–matched WT and GcKO mice. (B–D) Body composition from a selected group of WT and GcKO mice with matched body weight, where their body weights are shown in B, fat mass shown in C, and lean mass shown in D. (E) Body weights of WT and GcKO mice with matched body weight on the day of glucose tolerance tests. (F) Glucose tolerance tests in D. (G) AUC in E. (H) Body weights from a selected group of WT and GcKO mice with matching body weights on the day of pyruvate tolerance tests. (I) Pyruvate tolerance tests of mice in G. (J) AUC in H. Mice are males. WT n ≥ 8, GcKO n ≥ 8. Data are shown as mean ± SEM, *P < 0.05, **P < 0.01, ***P < 0.005 by Student’s t test.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts